Muscle Relaxants, Central
"Muscle Relaxants, Central" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)
| Descriptor ID |
D009125
|
| MeSH Number(s) |
D27.505.696.510 D27.505.696.663.700.600 D27.505.954.427.525
|
| Concept/Terms |
Muscle Relaxants, Central- Muscle Relaxants, Central
- Central Muscle Relaxants
- Relaxants, Central Muscle
- Centrally Acting Muscle Relaxants
|
Below are MeSH descriptors whose meaning is more general than "Muscle Relaxants, Central".
Below are MeSH descriptors whose meaning is more specific than "Muscle Relaxants, Central".
This graph shows the total number of publications written about "Muscle Relaxants, Central" by people in this website by year, and whether "Muscle Relaxants, Central" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Muscle Relaxants, Central" by people in Profiles.
-
Muehlschlegel S, Carandang R, Hall W, Kini N, Izzy S, Garland B, Ouillette C, van der Bom IM, Flood TF, Gounis MJ, Weaver JP, Barton B, Wakhloo AK. Dantrolene for cerebral vasospasm after subarachnoid haemorrhage: a randomised double blind placebo-controlled safety trial. J Neurol Neurosurg Psychiatry. 2015 Sep; 86(9):1029-35.
-
Muehlschlegel S, Rordorf G, Sims J. Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study. Stroke. 2011 May; 42(5):1301-6.
-
Atlas SJ, Tosteson TD, Blood EA, Skinner JS, Pransky GS, Weinstein JN. The impact of workers' compensation on outcomes of surgical and nonoperative therapy for patients with a lumbar disc herniation: SPORT. Spine (Phila Pa 1976). 2010 Jan 01; 35(1):89-97.
-
Muehlschlegel S, Rordorf G, Bodock M, Sims JR. Dantrolene mediates vasorelaxation in cerebral vasoconstriction: a case series. Neurocrit Care. 2009; 10(1):116-21.
-
Muehlschlegel S, Sims JR. Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit. Neurocrit Care. 2009; 10(1):103-15.
-
Dickson EW, Bird SB, Gaspari RJ, Boyer EW, Ferris CF. Diazepam inhibits organophosphate-induced central respiratory depression. Acad Emerg Med. 2003 Dec; 10(12):1303-6.
-
Dershwitz M, Sr?ter FA. Azumolene reverses episodes of malignant hyperthermia in susceptible swine. Anesth Analg. 1990 Mar; 70(3):253-5.